InvestorsHub Logo
Followers 165
Posts 19846
Boards Moderated 2
Alias Born 12/09/2004

Re: Investor2014 post# 463213

Tuesday, 07/02/2024 6:41:20 PM

Tuesday, July 02, 2024 6:41:20 PM

Post# of 463229
That outcome was unexpected due to the very good data from the Adult Rett trials and the expectation that treating Rett patients earlier in the disease process would yield even better results.

Wasn't the improvement in RSBQ better than that of Trofinetide P3?

Nunc est Bibendum

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News